Ignite Creation Date:
2024-05-05 @ 10:48 PM
Last Modification Date:
2024-10-26 @ 10:24 AM
Study NCT ID:
NCT01198626
Status:
TERMINATED
Last Update Posted:
2011-12-08
First Post:
2010-09-07
Brief Title:
Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia
Sponsor:
Furiex Pharmaceuticals Inc
Organization:
Furiex Pharmaceuticals Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Community-Acquired Bacterial Pneumonia CABP |
Keywords:
| Name | View |
|---|---|
| community-acquired bacterial pneumonia | View |
| CABP | View |
| CAP | View |
| pneumonia | View |
| pneumonia bacterial | View |
| bacterial infections | View |
| anti-bacterial agents | View |
| anti-infective agents | View |
| lung disease interstitial | View |
| respiratory tract diseases | View |
| respiratory tract infections | View |
| community-acquired infections | View |